FutureWise Research, a leading healthcare and life sciences market intelligence firm, today announces the release of its ...
Technological Advancements Drive Innovation in Medical Radiation Shielding SolutionsThe Global Medical Radiation Shielding ...
Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc.
The "Global Quantum Technology Market 2026-2046" report has been added to ResearchAndMarkets.com's offering.The global quantum technology market represents one of the most dynamic and strategically ...
ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, today announced the launch of its latest product: CHO cell–derived recombinant ...
The "Saudi Arabia Essential Oils Market by Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Saudi Arabia Essential Oils Market ...
Adults with Duchenne muscular dystrophy demonstrated functional improvements exceeding natural history, following 28-day treatment with SAT-3247Grip strength increased 118.6% and predicted forced ...
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseasesTransaction further ...
PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Some companies tiptoe into innovation. Healthcare Triangle Inc. (NASDAQ:HCTI) prefers to kick the door down. The Pleasanton-based digital health ...
FRAMINGHAM, MA / ACCESS Newswire / October 10, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
MESA, ARIZONA / ACCESS Newswire / October 10, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging leader in artificial intelligence-powered preventive health technologies, today ...
For Trade and Medical Media OnlyEnrolment completed in Phase III ReSPECT study in prophylaxis of fungal infections in adult patients undergoing allogeneic blood and marrow transplantTopline results ...